This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Review

. 2000 Oct;11(10):1933-1936.

doi: 10.1681/ASN.V11101933.

Cyclosporine avoidance

Philippe Gauthier¹, J Harold Helderman¹

Affiliations

PMID: 11004226
DOI: 10.1681/ASN.V11101933

Review

Cyclosporine avoidance

Philippe Gauthier et al. J Am Soc Nephrol. 2000 Oct.

. 2000 Oct;11(10):1933-1936.

doi: 10.1681/ASN.V11101933.

Authors

Philippe Gauthier¹, J Harold Helderman¹

Affiliation

¹ Division of Nephrology, Department of Medicine, and The Vanderbilt Transplant Center, Nashville, Tennesse.

PMID: 11004226
DOI: 10.1681/ASN.V11101933

No abstract available

PubMed Disclaimer

Comment on

Avoidance of cyclosporine in renal transplantation: effects of daclizumab, mycophenolate mofetil, and steroids.
Tran HTB, Acharya MK, McKay DB, Sayegh MH, Carpenter CB, Auchincloss H Jr, Kirkman RL, Milford EL. Tran HTB, et al. J Am Soc Nephrol. 2000 Oct;11(10):1903-1909. doi: 10.1681/ASN.V11101903. J Am Soc Nephrol. 2000. PMID: 11004222 Clinical Trial.

Publication types

Actions
Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions

LinkOut - more resources

Full Text Sources
- Wolters Kluwer
Medical
- MedlinePlus Health Information